Milestone’s CompuFlo Advisor Program Expands to Seven States, Targets Medicare Reimbursement Growth
MLSS•Since February 2026, Milestone’s Advisor Program has onboarded physician advisors and initiated CompuFlo® epidural procedures across seven states under Medicare Administrative Contractors Novitas, First Coast Service Options and Palmetto, with expansion into Noridian and NGS. The company has built a sales consultant network in nine states and partnered with three universities to advance clinical validation and reimbursement.
1. Advisor Program Expansion
Milestone launched its CompuFlo® Advisor Program in February 2026, onboarding physician advisors and initiating epidural procedures across seven states (NJ, FL, PA, NY, TN, TX, GA) under Medicare Administrative Contractors Novitas, First Coast Service Options and Palmetto. Initial case submissions have been filed with both Medicare and select commercial payers, and expansion into Noridian and NGS regions is underway.
2. Sales Network Growth
The company has established a growing network of sales consultant partners in nine states (NJ, NY, PA, FL, TX, WA, CA, OR, CO) targeting pain clinics, ambulatory surgery centers and hospitals. Digital and social media initiatives are generating inbound interest from medical professionals, converting advisors into direct purchasing accounts and driving device placements alongside procedural utilization.
3. Clinical Validation and Reimbursement Pathway
Milestone is collaborating with the University of Texas, University of Kansas and University of Minnesota to support clinical studies and training for CompuFlo®. The device currently holds CPT Category III code 0777T, with ongoing utilization and real-world data generation intended to meet criteria for Category I designation, while disposables sales underpin a scalable recurring revenue model.
